Comparison

Neutrophil elastase

Item no. 18-272-197794
Manufacturer GENWAY
Amount 0.25 ml
Category
Type Antibody
Applications ELISA
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-F4766D
Similar products 18-272-197794
Available
Genway ID:
GWB-F4766D
Isotype:
IgG
Immunogen:
Elastase (Human Neutrophil).
Antigen Species:
Human
Target:
Neutrophil elastase
Localization:
Cytoplasmic and Secreted
Concentration:
11. 45 mg/ml
Purification Note:
Ammonium sulfate precipitation. Single arc on IEP of neutrophil granule extract and human neutrophil elastase. Storage
Preservative:
0. 1% Sodium Azide. Constituents: PBS. pH 7. 5
Application Note:
I-ELISA: > 1/1000. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:
Cytoplasmic and Secreted Elastases form a subfamily of serine proteases that hydrolyse many proteins in addition to elastin. Neutrophil elastase (elastase 2) hydrolyses proteins within specialized neutrophil lysosomes called azurophil granules as well as proteins of the extracellular matrix following the protein\' s release from activated neutrophils. Elastase 2 may play a role in degenerative and inflammatory diseases by its proteolysis of collagen IV and elastin of the extracellular matrix. This protein degrades the outer membrane protein A (OmpA) of E. coli as well as the virulence factors of such bacteria as Shigella Salmonella and Yersinia. This gene is clustered with other serine protease gene family members azurocidin 1 and proteinase 3 genes at chromosome 19pter. All 3 genes are expressed coordinately and their protein products are packaged together into azurophil granules during neutrophil differentiation.
Function:
Modifies the functions of natural killer cells monocytes and granulocytes. Inhibits C5a-dependent neutrophil enzyme release and chemotaxis.
Catalytic Activity:
Hydrolysis of proteins including elastin. Preferential cleavage: Val-|-Xaa & gt; Ala-|-Xaa.
Subunit:
Interacts with NOTCH2NL.
Tissue Specificity:
Bone marrow cells.
Disease:
Defects in ELA2 are a cause of cyclic haematopoiesis (CH) [MIM:162800]; also known as cyclic neutropenia. CH is an autosomal dominant disease in which blood-cell production from the bone marrow oscillates with 21-day periodicity. Circulating neutrophils vary between almost normal numbers and zero. During intervals of neutropenia affected individuals are at risk for opportunistic infection. Monocytes platelets lymphocytes and reticulocytes also cycle with the same frequency.
Disease:
Defects in ELA2 are the cause of autosomal dominant severe congenital neutropenia type 1 (SCN1) [MIM:202700]. Severe congenital neutropenia is a heterogeneous disorder of hematopoiesis characterized by a maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0. 5 x 10(9)/l and early onset of severe bacterial infections.
Similarity:
Belongs to the peptidase S1 family. Elastase subfamily [view classification].
Similarity:
Contains 1 peptidase S1 domain [view classification].

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.25 ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close